Lewes, DE -- (SBWIRE) -- 10/02/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: VimpelCom Ltd (ADR) (NASDAQ:VIP), Hanwha Solarone Co Ltd (NASDAQ:HSOL), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Nuance Communications Inc. (NASDAQ:NUAN).
VimpelCom Ltd (ADR) (NASDAQ:VIP), increased 5.96% and closed at $12.45 on a traded volume of 4.27 million shares, in comparison to 1.05 million shares of average trading volume. So far this year, the stock is up over 18.68%.
The company has a total market capitalization of $25.56 million and its total outstanding shares are 2.05 million.
Will VIP Continue To Move Higher? Find Out Here
Nuance Communications, Inc. provides voice and language solutions for businesses and consumers worldwide. It provides dictation and transcription solutions and services that enable platforms to generate and distribute clinical documentation; clinical documentation improvement programs; and speech recognition solutions for radiology, cardiology, pathology, and related specialties enabling healthcare providers to dictate, edit, and sign reports without manual transcription.
Hanwha Solarone Co Ltd (NASDAQ:HSOL), soared7.42% and closed at $4.78 on a traded volume of 4.18 million shares, whereas its average trading volume is 2.05 million shares. In the last three months, the stock is up100%. The Intra-day range for the stock is $4.60 and $4.95.
For How Long HSOL’s Gloss will Attract Investors? Find out via this report
Hanwha Solarone Co., Ltd., an investment holding company, engages in the manufacture and sale of silicon ingots, silicon wafers, photovoltaic (PV) cells, and PV modules. It provides mono crystalline and multi crystalline silicon cells; PV module processing services; and construction services to build solar power systems.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), jumped up2.66% and closed at $18.89. So far in three months, the stock is down -3.28%. The 52-week range for the stock is $15.35 and $25.40 and during the previous trading session it marked$18.90 as its highest price. The stock initially exchanged hands with a price of $18.55 and the overall traded volume that day was 4.15 million shares.
Will ARIA Continue To Move Higher? Find Out Here
ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients.
Nuance Communications Inc. (NASDAQ:NUAN) after opening its shares at the price of $18.71, jumped up18.98% to close the day at $18.98. The stock ended on a traded volume of 4.14 million shares, in comparison to 3.93 million shares of average trading volume. The 52-week range for the stock is $17.90 and $25.33 and during the previous trading session the stock scored the highest price of $19.03. It started the day at $18.71.
Why Should Investors Buy NUAN After The Recent Gain? Just Go Here and Find Out.
Nuance Communications, Inc. provides voice and language solutions for businesses and consumers worldwide. It provides dictation and transcription solutions and services that enable platforms to generate and distribute clinical documentation; clinical documentation improvement programs; and speech recognition solutions for radiology, cardiology, pathology, and related specialties enabling healthcare providers to dictate, edit, and sign reports without manual transcription.
About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/